| Application no. and date | 15720269.8 (espacenet) (Federated) (European Patent Register), 20150326 | | Patent/reg. no. and date | DK/EP 3122742, 20180919 | | Publication date | 20170201 | | Priority no. and date | EP 14161820, 20140326 | | EP pub. no. and date |
EP 3122742 20170201 | | Effective date | | | Applicant/owner | Astex Therapeutics Ltd, 436 Cambridge Science Park,
Milton Road,
Cambridge
Cambridgeshire CB4 0QA, GB | | Applicant ref. no. | V1811-100-DK | | Inventor | VERMEULEN, Wim, Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse, BE,
HOSTYN, Steven Anna, Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse, BE,
CUYCKENS, Filip Albert Celine, Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse, BE,
JONES, Russell Mark, Bruderholzstrasse 38
4102 Binningen, CH,
BROGGINI, Diego Fernando Domenico, Cilag AG
Hochstrasse 201
8200 Schaffhausen, CH | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/4985 (2006.01) , A61P 35/00 (2006.01) , C07D 403/14 (2006.01) | | Title | ANVENDELIGE QUINOXALINDERIVATER SOM FGFR-KINASEMODULATORER | | Int. application no. | EP2015056507 | | Int. publication no. | WO2015144803 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
